NeOnc among Names with 2026 Breakthroughs that Offer New Hope in the Fight Against Cancer
NeOnc’s encouraging brain-cancer survival findings join 20206 developments from $RVMD, $MRNA, $MRK, $JNJ, $GMAB and $ABBV.
Covered in this story
Call it yourself
No calls on $RVMD yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Revolution Medicines →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.